BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9764578)

  • 1. Establishment of a retinoic acid-resistant human acute promyelocytic leukaemia (APL) model in human granulocyte-macrophage colony-stimulating factor (hGM-CSF) transgenic severe combined immunodeficiency (SCID) mice.
    Fukuchi Y; Kizaki M; Kinjo K; Awaya N; Muto A; Ito M; Kawai Y; Umezawa A; Hata J; Ueyama Y; Ikeda Y
    Br J Cancer; 1998 Oct; 78(7):878-84. PubMed ID: 9764578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.
    Kizaki M; Matsushita H; Takayama N; Muto A; Ueno H; Awaya N; Kawai Y; Asou H; Kamada N; Ikeda Y
    Blood; 1996 Sep; 88(5):1824-33. PubMed ID: 8781440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review).
    Kizaki M; Fukuchi Y; Ikeda Y
    Int J Mol Med; 1999 Oct; 4(4):359-64. PubMed ID: 10493975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A; Kizaki M; Kawamura C; Matsushita H; Fukuchi Y; Umezawa A; Yamada T; Hata J; Hozumi N; Yamato K; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2001 Aug; 15(8):1176-84. PubMed ID: 11480559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice.
    Zhang SY; Zhu J; Chen GQ; Du XX; Lu LJ; Zhang Z; Zhong HJ; Chen HR; Wang ZY; Berger R; Lanotte M; Waxman S; Chen Z; Chen SJ
    Blood; 1996 Apr; 87(8):3404-9. PubMed ID: 8605358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of human granulocyte-macrophage colony stimulating factor producing transgenic SCID mice.
    Miyakawa Y; Fukuchi Y; Ito M; Kobayashi K; Kuramochi T; Ikeda Y; Takebe Y; Tanaka T; Miyasaka M; Nakahata T; Tamaoki N; Nomura T; Ueyama Y; Shimamura K
    Br J Haematol; 1996 Dec; 95(3):437-42. PubMed ID: 8943881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.
    Imaizumi M; Sato A; Koizumi Y; Inoue S; Suzuki H; Suwabe N; Yoshinari M; Ichinohasama R; Endo K; Sawai T
    Leukemia; 1994 Aug; 8(8):1301-8. PubMed ID: 7520101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells.
    Witcher M; Shiu HY; Guo Q; Miller WH
    Blood; 2004 Nov; 104(10):3335-42. PubMed ID: 15256426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human acute myeloblastic leukemia-ascites model using the human GM-CSF- and IL-3-releasing transgenic SCID mice.
    Fukuchi Y; Miyakawa Y; Kizaki M; Umezawa A; Shimamura K; Kobayashi K; Kuramochi T; Hata J; Ikeda Y; Tamaoki N; Nomura T; Ueyama Y; Ito M
    Ann Hematol; 1999 May; 78(5):223-31. PubMed ID: 10391103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DT388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte-macrophage colony-stimulating factor, prolongs host survival in a SCID mouse model of acute myeloid leukemia.
    Hall PD; Willingham MC; Kreitman RJ; Frankel AE
    Leukemia; 1999 Apr; 13(4):629-33. PubMed ID: 10214872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells.
    Sakashita A; Nakamaki T; Tsuruoka N; Honma Y; Hozumi M
    Leukemia; 1991 Jan; 5(1):26-31. PubMed ID: 1705636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of PML/RARalpha impairs myelopoiesis.
    Early E; Moore MA; Kakizuka A; Nason-Burchenal K; Martin P; Evans RM; Dmitrovsky E
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7900-4. PubMed ID: 8755574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia.
    Westervelt P; Pollock JL; Oldfather KM; Walter MJ; Ma MK; Williams A; DiPersio JF; Ley TJ
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9468-73. PubMed ID: 12077315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine dependent growth of human TF-1 leukemic cell line in human GM-CSF and IL-3 producing transgenic SCID mice.
    Fukuchi Y; Miyakawa Y; Kobayashi K; Kuramochi T; Shimamura K; Tamaoki N; Nomura T; Ueyama Y; Ito M
    Leuk Res; 1998 Sep; 22(9):837-43. PubMed ID: 9716016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-colony stimulating factor and retinoic acid cooperatively induce granulocyte differentiation of acute promyelocytic leukemia cells in vitro.
    Nakamaki T; Sakashita A; Sano M; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
    Jpn J Cancer Res; 1989 Nov; 80(11):1077-82. PubMed ID: 2481663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.